xmt-2056
·Code: XMT-2056
xmt-2056: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Mersana Therapeutics, Inc. (MRSN) | Phase 1 |
Clinical Trials (1)
A Phase 1, First-in-Human, Dose Escalation and Expansion, Multicenter Study of XMT-2056 in Participants With Advanced/Recurrent Solid Tumors That Express HER2
Frequently asked questions
Who is developing xmt-2056?
xmt-2056 is being developed by Mersana Therapeutics, Inc..
How many clinical trials involve xmt-2056?
BioSniper tracks 1 clinical trial involving xmt-2056.
Get deeper analysis on xmt-2056
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis